Tetanus clinical trials
The registry lists 198 studies for Tetanus across more than 10 countries. 21 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 158
- Not yet recruiting
- 12
- Status unknown
- 8
- Recruiting
- 8
- Active, not recruiting
- 8
- Terminated
- 3
Phase
- Phase 3
- 83
- Phase 4
- 40
- Phase 2
- 26
- Phase 1
- 23
- Early Phase 1
- 1
Where
- United States
- 37
- China
- 34
- Canada
- 11
- Korea, Republic of
- 11
- France
- 10
- Philippines
- 8
Who runs them
Sanofi Pasteur, a Sanofi Company (49) · GlaxoSmithKline (33) · Sanofi (17) · CanSino Biologics Inc. (10) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · Zhuhai Trinomab Pharmaceutical Co., Ltd. (5) · Sinovac Life Sciences Co., Ltd. (3) · Crucell Holland BV (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 198 — search for more.
- PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMANot yet recruitingNCT07828236Phase 11 country
- Observation of Immune Persistence in a Clinical Trial of an Adsorbed Tetanus VaccineNot yet recruitingNCT078070331 country
- Study of BK1803 in Healthy InfantsNot yet recruitingNCT07793513Phase 31 country
- A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined VaccineNot yet recruitingNCT07744347
- A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following InjuryRecruitingNCT073479381 country
- A Phase Ⅲ Clinical Study of SNA02-48 InjectionNot yet recruitingNCT07633119Phase 31 country
- A First in Human Study Investigating the Safety of an Unloaded and Loaded (With a Tetanus-containing Vaccine Booster) Microneedle Patch in Healthy AdultsNot yet recruitingNCT07624669Phase 4
- Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months OldNot yet recruitingNCT07621341Phase 41 country
- Tetanus Severity Score for Prediction of Mortality in Manifest TetanusRecruitingNCT075121671 country
- Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme TrialRecruitingNCT06815250Not applicable1 country
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)Not yet recruitingNCT07492303Phase 1
- TETANUS Antibody Detection in Saliva StudyNot yet recruitingNCT07446166Not applicable1 country
- Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) VaccineNot yet recruitingNCT07418372Phase 1/21 country
- Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody InjectionEnrolling by invitationNCT07149454Phase 11 country
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT073589101 country
- A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following InjuryRecruitingNCT071079321 country
- Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined VaccineRecruitingNCT07203755Phase 11 country
- Study of Concomitant Administration of the sIPV and DTaP or MMRNot yet recruitingNCT06920069Phase 41 country
- A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 InjectionRecruitingNCT06635798Phase 31 country
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination FormulationNot yet recruitingNCT06360250Early Phase 1
- Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined VaccineRecruitingNCT06184542Phase 11 country
- Phase I Clinical Trial of Adsorbed Tetanus VaccineActive, not recruitingNCT07598890Phase 11 country
- A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant WomenActive, not recruitingNCT07596199Phase 31 country
- Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary SeriesCompletedNCT05457946Phase 2/31 country
- A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesActive, not recruitingNCT06947499Phase 2/31 country
- Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against TetanusCompletedNCT05664750Phase 31 country
- A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)CompletedNCT06708286Phase 2/31 country
- A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)CompletedNCT06056050Phase 11 country
- A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and OverCompletedNCT06120751Phase 31 country
- Phase I/III Clinical Trial of Adsorbed Tetanus VaccineCompletedNCT07740733Phase 31 country
- A Study of Tetanus Antibody of Healthy AdultsCompletedNCT077243791 country
- Safety and Immunogenicity Study of Tdap Vaccinations for Plasma DonorsCompletedNCT05662852Phase 21 country
- Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceActive, not recruitingNCT060709611 country
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult ParticipantsCompletedNCT06939777Phase 1/21 country
- Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021CompletedNCT049393501 country
- Safety Monitoring of Boostagen® Vaccine in ThailandCompletedNCT074445021 country
- Study of BK1301 (DTaP Vaccine) as a Booster in AdolescentsCompletedNCT02118961Phase 31 country
- Confirmatory Study of BK1310 in Healthy InfantsCompletedNCT03891758Phase 31 country
- PFAS Exposure and Immune Response to Vaccination in AdultsCompletedNCT06588530Phase 41 country
- Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult VolunteersCompletedNCT05625477Phase 21 country
- A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, AdsorbedActive, not recruitingNCT05091619Phase 31 country
- Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined VaccineActive, not recruitingNCT06857370Phase 31 country
- Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their InfantsCompletedNCT03589768Phase 22 countries
- A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)Active, not recruitingNCT05951725Phase 31 country
- Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis VaccineCompletedNCT06817187Phase 31 country
- A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and OverCompletedNCT06123663Phase 11 country
- A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus VaccineCompletedNCT06607380Phase 11 country
- Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old PopulationCompletedNCT06049940Phase 31 country
- Real-time Artificial Intelligent (AI)-Assisted Muscle Ultrasound for Monitoring Muscle Mass Reduction in ICU PatientsCompletedNCT06034093Not applicable1 country
- Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell TransplantationTerminatedNCT02700841Phase 21 country